- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Omeros Corp+ Add to Watchlist
OMER:US7.3600 USD 0.0500 0.68%
As of 20:10:00 ET on 12/09/2013.
Company Profile for Omeros Corp (OMER)
Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management.
Key Executives for Omeros Corp (OMER)
|Gregory A DemopulosChairman/Pres/CEO/Co-Founder||J Steven WhitakerChief Medical Officer|
|Albert S YuVP:Clinical Development||Michael K InouyeVP:Commercial Operations|
|Michael A JacobsenVP:Finance/Chief Acctg Officer||Marcia S KelbonVP:Patent/Secy/General Counsel|
|Catherine A Melfi "Cathy"VP:Regulatory Affairs|